Literature DB >> 21150682

Predictors of volumetric growth and auditory deterioration in vestibular schwannomas followed in a wait and scan policy.

Rick van de Langenberg1, Bert-J de Bondt, Patty J Nelemans, Amy J C Dohmen, Brigitta G Baumert, Robert J Stokroos.   

Abstract

OBJECTIVE: The purpose of this study was to identify factors predicting growth and audiologic deterioration during follow-up (FU) in a wait and scan (W&S) policy of vestibular schwannomas (VSs) using a novel volumetric measuring tool. So far, only consecutive magnetic resonance imaging (MRI) is able to show growth objectively, and growth, combined with hearing function, generally dictates further intervention. Other factors predicting growth or hearing deterioration would be invaluable and might ease clinical decision making. STUDY
DESIGN: Retrospective case study.
SETTING: Tertiary referral center. PATIENTS: Sixty-three patients diagnosed with VS at Maastricht University Medical Center between 2003 and 2008, with FU data available from 36 patients. INTERVENTION(S): A W&S policy for unilateral VS with sequential contrast-enhanced T1- and T2-weighted MRI and audiograms during FU. MAIN OUTCOME MEASURE(S): 1. Patient and radiologic VS features potentially related to growth and auditory function during a W&S policy. 2. The correlation between increase in VS volume and audiologic deterioration during FU.
RESULTS: Labyrinthine hypointensity on T2-weighted magnetic resonance images and complaints of hearing loss at presentation are predictive of a faster deterioration of hearing (p < 0.05). Growth during the first FU year predicts further growth. Vestibular schwannoma volume does not correlate with audiologic deterioration significantly.
CONCLUSION: Hypointensity on T2-weighted image of the affected labyrinth will result in a significant faster deterioration of hearing. Hearing loss was more profound, and hearing will deteriorate significantly faster in patients presenting with complaints of hearing loss. Significant growth during the first year of FU predicts further growth during FU. Sequential MRI cannot be substituted by audiologic examinations solely because increase in VS volume does not correlate with audiologic deterioration significantly.

Entities:  

Mesh:

Year:  2011        PMID: 21150682     DOI: 10.1097/MAO.0b013e3182040d9f

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  17 in total

1.  Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma.

Authors:  Anthony M Tolisano; Jacob B Hunter
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

2.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

3.  The impact of MRI steady-state sequences as an additional assessment modality in vestibular schwannoma patients after LINAC stereotactic radiotherapy or radiosurgery.

Authors:  Julian P Sauer; Thomas M Kinfe; Bogdan Pintea; Andreas Schäfer; Jan P Boström
Journal:  Strahlenther Onkol       Date:  2018-05-23       Impact factor: 3.621

4.  The prediction of the tumor size of a vestibular schwannoma by clinical performance and vestibular function tests.

Authors:  Yujuan Zhou; Weidong Zhao; Liang Tian; Jing Yu; Yasheng Yuan; Jing Wang
Journal:  J Neurooncol       Date:  2018-09-20       Impact factor: 4.130

5.  Hypofractionated stereotactic radiotherapy of acoustic neuroma: volume changes and hearing results after 89-month median follow-up.

Authors:  Manfred Kranzinger; Franz Zehentmayr; Gerd Fastner; Gerhard Oberascher; Florian Merz; Olaf Nairz; Hassan Rahim; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

6.  The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

7.  A standardised pathway for the surveillance of stable vestibular schwannoma.

Authors:  J Shapey; K Barkas; S Connor; A Hitchings; H Cheetham; S Thomson; J M U-King-Im; R Beaney; D Jiang; S Barazi; R Obholzer; Nwm Thomas
Journal:  Ann R Coll Surg Engl       Date:  2018-03       Impact factor: 1.891

8.  An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth.

Authors:  Nicolas-Xavier Bonne; Jérémie Vitte; Fabrice Chareyre; Gevorg Karapetyan; Vazgen Khankaldyyan; Karo Tanaka; Rex A Moats; Marco Giovannini
Journal:  J Neurooncol       Date:  2016-05-13       Impact factor: 4.130

9.  A Xenograft Model of Vestibular Schwannoma and Hearing Loss.

Authors:  Christine T Dinh; Olena Bracho; Christine Mei; Esperanza Bas; Cristina Fernandez-Valle; Fred Telischi; Xue-Zhong Liu
Journal:  Otol Neurotol       Date:  2018-06       Impact factor: 2.311

10.  Identifying predictors of early growth response and adverse radiation effects of vestibular schwannomas to radiosurgery.

Authors:  Soroush Larjani; Eric Monsalves; Houman Pebdani; Boris Krischek; Fred Gentili; Michael Cusimano; Normand Laperriere; Caroline Hayhurst; Gelareh Zadeh
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.